[Tuberculous otitis media: A case presentation and review of european literature].
Otitis media tuberculosa: Presentación de un caso y revisión de la literatura europea.
Mycobacterium tuberculosis
antituberculous therapy
chronic otitis media
otitis media
Journal
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
ISSN: 1988-9518
Titre abrégé: Rev Esp Quimioter
Pays: Spain
ID NLM: 9108821
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
medline:
25
9
2023
pubmed:
2
6
2023
entrez:
2
6
2023
Statut:
ppublish
Résumé
Tuberculous otitis media (TOM) is a rare affectation in our environment that represents a challenge in its diagnosis due to the non-specific symptoms that it usually presents. This paper presents our experience in the diagnosis of a case of TOM in a 66-year-old woman with hearing loss and chronic otorrhea of more than 6 months of evolution that did not respond to conventional treatments. In addition, a review of the cases published in the last 20 years (2000-2022) in countries of the European Union (EU) is carried out. The most common symptoms were otorrhea (n=43; 100%), hearing loss (n=37; 86.05%), eardrum perforation (n=19; 44.18%), facial paralysis (n=12, 27,91%) and ear pain (n=13; 30,23%). The most used sample for diagnosis was the biopsy obtained by mastoidectomy (n=34; 79.06%). All patients were given antituberculous therapy for a mean duration of 8.11 months (range, 6-12 months). The most frequent aftereffect was hearing loss (n=28; 65.12%). TOM should be included in the differential diagnosis of chronic suppurative otitis, since early diagnosis and treatment reduce the probability of suffering irreversible sequelae.
Identifiants
pubmed: 37265448
doi: 10.37201/req/011.2023
pmc: PMC10586746
pii:
doi:
Types de publication
Case Reports
Review
English Abstract
Journal Article
Langues
spa
Sous-ensembles de citation
IM
Pagination
519-525Informations de copyright
©The Author 2023. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
Références
J Infect. 2010 Jul;61(1):96-9
pubmed: 20394770
Eur Arch Otorhinolaryngol. 2014 Jul;271(7):2083-9
pubmed: 24609650
Med Mal Infect. 2008 Nov;38(11):608-11
pubmed: 18954947
J Craniofac Surg. 2020 Sep;31(6):e552-e553
pubmed: 32371689
Am J Otolaryngol. 2022 Sep-Oct;43(5):103571
pubmed: 35963106
Int J Pediatr Otorhinolaryngol. 2002 Aug 1;65(1):59-63
pubmed: 12127224
BMJ Case Rep. 2020 Dec 9;13(12):
pubmed: 33298491
Case Rep Infect Dis. 2011;2011:932608
pubmed: 22570801
J Laryngol Otol. 2011 Jul;125(7):738-40
pubmed: 21693076
BMJ Case Rep. 2010 Dec 01;2010:
pubmed: 22798297
J Surg Case Rep. 2019 Apr 03;2019(4):rjz093
pubmed: 30967931
Pathol Res Pract. 2002;198(1):31-5
pubmed: 11866208
Eur Radiol. 2009 Jun;19(6):1560-3
pubmed: 19440720
Infect Dis (Lond). 2017 Mar;49(3):223-224
pubmed: 27389342
Auris Nasus Larynx. 2001 Aug;28(3):241-3
pubmed: 11489368
An Pediatr (Barc). 2006 Jan;64(1):104-6
pubmed: 16539928
Case Rep Med. 2011;2011:675807
pubmed: 21541186
Laryngoscope. 1953 Nov;63(11):1058-77
pubmed: 13110208
J Int Adv Otol. 2016 Aug;12(2):219-221
pubmed: 27716611
J Clin Microbiol. 2015 Jan;53(1):336-8
pubmed: 25339389
BMJ Case Rep. 2022 Aug 25;15(8):
pubmed: 36007975
Laryngorhinootologie. 2008 Jul;87(7):503-6
pubmed: 18688924
Arch Pediatr. 2006 Sep;13(9):1233-5
pubmed: 16829062
J Infect Public Health. 2021 Jan;14(1):139-142
pubmed: 33234409
Rev Esp Quimioter. 2018 Apr;31(2):182-183
pubmed: 29616516
Acta Otorhinolaryngol Ital. 2015 Apr;35(2):125-8
pubmed: 26019398
Otolaryngol Head Neck Surg. 2004 Jun;130(6):759-66
pubmed: 15195064
Scand J Infect Dis. 2000;32(4):436-8
pubmed: 10959661